Dolatrai Vyas - 17 Jun 2021 Form 4 Insider Report for SPECTRUM PHARMACEUTICALS INC

Role
Director
Signature
/s/ Kurt A. Gustafson, attorney-in-fact for Dolatrai Vyas
Issuer symbol
N/A
Transactions as of
17 Jun 2021
Net transactions value
-$38,160
Form type
4
Filing time
22 Jun 2021, 17:06:23 UTC
Next filing
22 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPPI Common Stock, $0.001 par value Award $0 +14,277 +18% $0.000000 95,346 17 Jun 2021 Direct F1
transaction SPPI Common Stock, $0.001 par value Sale $38,160 -9,000 -9.4% $4.24 86,346 18 Jun 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPPI Stock Option (Right to Buy) Award $0 +67,804 $0.000000 67,804 17 Jun 2021 Common Stock 67,804 $4.29 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the restricted shares shall vest on the earlier of (1) June 17, 2022 or (2) the date of the company's 2022 Annual Meeting of Stockholders.
F2 All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
F3 One third of the aggregate amount of option shares shall vest on each of June 17, 2022, 2023 and 2024, respectively.